Cullin-RING E3 Ubiquitin Ligase Complex (CRL)

The Cullin-RING E3 ubiquitin ligase complex (CRL) is a large and diverse superfamily of multi-subunit E3 ubiquitin ligases found in all eukaryotes. These complexes play a central role in the ubiquitination pathway, which tags proteins for degradation by the 26S proteasome or modulates their function through other types of ubiquitination. CRLs are responsible for approximately 20% of all protein ubiquitylation events in cells. CRLs are modular assemblies built around a cullin scaffold protein. The core components include: cullin protein, RING finger protein (RBX1 or RBX2), adaptor proteins, and substrate receptor proteins. This modular organization allows for great diversity in substrate recognition. The CRL complex facilitates transfer of activated ubiquitin from an E2 enzyme directly onto lysine residues on target substrates via its RING domain. This process marks substrates for proteasomal degradation or alters their cellular functions depending on the type and pattern of polyubiquitin chains attached. A key regulatory step is neddylation, where the small protein NEDD8 is covalently attached to a conserved lysine residue on the cullin subunit. Neddylation enhances CRL activity by promoting conformational changes that facilitate efficient substrate ubiquitylation. CRLs regulate numerous essential cellular processes including: Cell cycle progression, DNA repair, Hypoxia signaling, Response to oxidative stress. Given their central role in controlling protein stability—especially those involved in cell cycle regulation—dysregulation or mutation within CRLs can contribute to cancer development and other diseases. As such, they have become attractive targets for drug discovery efforts aimed at modulating specific components or activities within these complexes.

Inhibition of CRL complex activity, targeting specific interfaces (e.g., Skp1/Skp2)